DNA mismatch repair deficiency accelerates endometrial tumorigenesis in pten heterozygous mice

被引:62
作者
Wang, H
Douglas, W
Lia, M
Edelmann, W
Kucherlapati, R
Podsypanina, K
Parsons, R
Ellenson, LH
机构
[1] Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA
[2] Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10467 USA
[3] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA
[4] Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA
关键词
D O I
10.1016/S0002-9440(10)62573-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
PTEN mutation and microsatellite instability are two of the most common genetic alterations in uterine endometrioid carcinoma. Furthermore, previous studies have suggested an association between the two alterations, however the basis and consequence of the association is not understood. Recently it has been shown that 100% of female Pten(+/-) mice develop complex atypical hyperplasia by 32 weeks of age that progresses to endometrial carcinoma in similar to20 to 25% of mice at 40 weeks. In an attempt to expand this mouse model of endometrial tumorigenesis and to further our understanding of the association between Pten mutations and DNA mismatch repair deficiency, we generated Pten heterozygous, Mlh1-null (mismatch repair deficient) mice. Significantly, the majority of Pten(+/-)/Mlh1(-/-) mice developed polypoid lesions in the endometrium at 6 to 9 weeks of age. By 14 to 18 weeks, all of the double-mutant mice had lesions histologically similar to those seen in Pten(+/-) mice, and two of them exhibited invasive disease. Moreover, the frequency of loss of the wildtype Pten allele in the double-mutant mice at 14 to 18 weeks was similar to that seen in lesions from 40-week-old Pten(+/-) mice. Taken together, our results indicate that DNA mismatch repair deficiency can accelerate endometrial tumorigenesis in Pten heterozygous mice and suggests that loss of the wild-type Pten allele is involved in die development/progression of tumors in this setting.
引用
收藏
页码:1481 / 1486
页数:6
相关论文
共 32 条
  • [1] Stepwise deletions of PolyA sequences in mismatch repair-deficient colorectal cancers
    Blake, C
    Tsao, JL
    Wu, A
    Shibata, D
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (05) : 1867 - 1870
  • [2] PTEN mutations in endometrial carcinomas: A molecular and clinicopathologic analysis of 38 cases
    Bussaglia, E
    del Rio, E
    Matias-Guiu, X
    Prat, J
    [J]. HUMAN PATHOLOGY, 2000, 31 (03) : 312 - 317
  • [3] Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability
    Cohn, DE
    Basil, JB
    Venegoni, AR
    Mutch, DG
    Rader, JS
    Herzog, TJ
    Gersell, DJ
    Goodfellow, PJ
    [J]. GYNECOLOGIC ONCOLOGY, 2000, 79 (01) : 101 - 106
  • [4] PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies
    Dahia, PLM
    Aguiar, RCT
    Alberta, J
    Kum, JB
    Caron, S
    Sill, H
    Marsh, DJ
    Ritz, J
    Freedman, A
    Stiles, C
    Eng, C
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (02) : 185 - 193
  • [5] Meiotic pachytene arrest in MLH1-deficient mice
    Edelmann, W
    Cohen, PE
    Kane, M
    Lau, K
    Morrow, B
    Bennett, S
    Umar, A
    Kunkel, T
    Cattoretti, G
    Chaganti, R
    Pollard, JW
    Kolodner, RD
    Kucherlapati, R
    [J]. CELL, 1996, 85 (07) : 1125 - 1134
  • [6] Edelmann W, 1999, CANCER RES, V59, P1301
  • [7] MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas
    Esteller, M
    Levine, R
    Baylin, SB
    Ellenson, LH
    Herman, JG
    [J]. ONCOGENE, 1998, 17 (18) : 2413 - 2417
  • [8] hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis
    Esteller, M
    Catasus, L
    Matias-Guiu, X
    Mutter, GL
    Prat, J
    Baylin, SB
    Herman, JG
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (05) : 1767 - 1772
  • [9] Gurin CC, 1999, CANCER RES, V59, P462
  • [10] Mouse models for colorectal cancer
    Heyer, J
    Yang, K
    Lipkin, M
    Edelmann, W
    Kucherlapati, R
    [J]. ONCOGENE, 1999, 18 (38) : 5325 - 5333